Both in Pharmaceuticals
Jupiter Neurosciences vs Aptevo Therapeutics
Over the past year JUNS returned −98.1% and APVO returned −92.8%; their daily moves had a correlation of -0.02.
JUNS −98.1% APVO −92.8%Growth of $1, one year, split-adjusted
| Metric | JUNS | APVO |
|---|---|---|
| Price | $2.58 | $1.86 |
| Market cap | $3.4M | $3.4M |
| Today | +2.79% | −2.62% |
| 1 month | −38.3% | −21.4% |
| 6 months | −89.4% | −53.0% |
| Year to date | −96.6% | −80.3% |
| 1 year | −97.8% | −93.1% |
| Revenue growth (YoY) | — | — |
| Gross margin | 86.9% | — |
| Net margin | −9380.9% | — |
| P/E (TTM) | — | — |
| Price / sales | 52.6× | — |
| Net cash | -$6.6K | $9.8M |
| Dividend yield | — | — |
| Volatility (60d) | 1,269.4% | 115.8% |
| Short % of float | 0.2% | 15.9% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).